Menu

Blog

Dec 19, 2022

Life-changing: New gene therapy gel heals decades-old wounds from skin disease

Posted by in category: biotech/medical

A gene therapy gel for a blistering skin disease developed at Stanford Medicine has worked wonders in a double-blind, placebo-controlled clinical trial.

The gel, called B-VEC, was intended to treat dystrophic epidermolysis bullosa, a skin disease that results in large open wounds that last for decades. The condition is extremely painful, and the medical treatment is mostly limited to palliative care.

Comments are closed.